Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.

导出 OA

翻译打印收藏纠错

作者： Muhammad Wasif M,Saif ^[1] ; Ruchi,Hamal ^[2] ; Nauman,Siddiqui ^[2] ; Antonia,Maloney ^[2] ; Melissa,Smith ^[2]

作者单位： Northwell Health Cancer Institute, Medical Oncology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 1111 Marcus Avenue, Lake Success, NY 11042, USA. ^[1] Tufts Medical Center, Boston, MA, USA. ^[2]

关键词 5-Fluorouracil DPYD TYMS anal cancer anus capecitabine cisplatin fluoropyrimidines mitomycin pharmacogenetics radiation

DOI 10.1177/17562848211024464

PMID 34276810

发布时间 2022-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in gastroenterology

2021年14卷

17562848211024464页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.

Therapeutic advances in gastroenterology

相似文献

Therapeutic advances in gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.

Therapeutic advances in gastroenterology

相似文献

Therapeutic advances in gastroenterology

相关期刊

检索历史清除